moderate-to-severe ADADmoderate-to-severe atopic dermatitisbaricitinibabrocitinibdupilumablebrikizumabtralokinumabupadacitinib
…ovide comparative efficacy data on therapeutic alternatives for moderate-to-severe AD in terms of IGA 0-1. Statistically significant benefit was obse…